SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Scott H. Davis who wrote (2193)8/10/1998 5:54:00 PM
From: tanzan  Respond to of 4676
 
Positive development for biotechs reported on editorial page of WSJ, August 10, at least positive for those biotechs operating in NJ and positive for others if the States they operate in follow NJ's lead. NJ will allow firms operating in the State to sell their tax loss carryovers to other firms. They won't earn dollar for dollar but what they do earn will obviate the need to issue additional shares to fund research and testing.